Orexins and appetite: The big picture of energy homeostasis gets a little bigger
Michael W. Schwartz
Department of Medicine, University of Washington and VA Puget Sound Health Care System Seattle, Washington 98108, USA email: mschwart@u.washington.edu
The discovery of orexins adds to a rapidly evolving picture of how food intake and body fat are regulated.
REFERENCES
Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell92, 573−585 (1998). | Article | PubMed | ISI | ChemPort |
Schwartz, M. & Seeley, R. Neuroendocrine responses to starvation and weight loss. New Engl. J. Med.336, 1802−1811 (1997). | Article | PubMed | ISI | ChemPort |
Stephens, T.W. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature377, 530−532 (1995). | Article | PubMed | ISI | ChemPort |
Schwartz, M.W. et al. Leptin increases proopiome-lanocortin (POMC) mRNA expression in the rostral arcuate nucleus. Diabetes46, 2119−2123 (1997). | PubMed | ISI | ChemPort |
Cone, R. et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Progress In Hormone Research51, 287−318 (1996). | PubMed | ISI | ChemPort |
Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell88, 131−141 (1997). | Article | PubMed | ISI | ChemPort |
Ollmann, M. et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science278, 135−138 (1997). | Article | PubMed | ISI | ChemPort |
Seeley, R. et al. Evidence that the hypothalamic melanocortin system mediates leptin's effects on food intake and body weight. Nature390, 349 (1997). | Article | PubMed | ChemPort |
Stanley, B.G., Kyrkouli, S.E., Lampert, S. & Leibowitz, S.F. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides7, 1189−1192 (1986). | Article | PubMed | ISI | ChemPort |
Rossi, M. et al. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology138, 351−155 (1997). | Article | PubMed | ISI | ChemPort |
Smith, B., York, D. & Bray, G. Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides15, 1267−1272 (1994). | Article | PubMed | ISI | ChemPort |
Schaffhauser, A.O. et al. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynu-cleotides. Diabetes46, 1792−1798 (1997). | PubMed | ISI | ChemPort |
Erickson, J.C., Clegg, K.E. & Palmiter, R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature381, 415−418 (1996). | Article | PubMed | ISI | ChemPort |
Connolly, H. et al. Valvular heart disease associated with fenfluramine-phentermine. New Engl. J. Med.337, 581−588 (1997). | Article | PubMed | ISI | ChemPort |